Guidance for Chief Pharmacists to support deployment of COVID-19 neutralising monoclonal antibodies

Read first

Implementation of effective process control is essential to ensure that neutralising monoclonal antibody products are implemented safely.

Treatments in CMDUs

Chief Pharmacists may need to oversee and manage prescription and supply of nMABs and oral antivirals in CMDUs. Use our framework and resources to help.
Three models exist for the supply and administration of COVID-19 treatments through CMDUs. We guide through the risks and mitigations associated with each.